FI107122B - Menetelmä virusten suhteen inaktivoitujen immunoglobuliiniliuosten valmistamiseksi - Google Patents

Menetelmä virusten suhteen inaktivoitujen immunoglobuliiniliuosten valmistamiseksi Download PDF

Info

Publication number
FI107122B
FI107122B FI923425A FI923425A FI107122B FI 107122 B FI107122 B FI 107122B FI 923425 A FI923425 A FI 923425A FI 923425 A FI923425 A FI 923425A FI 107122 B FI107122 B FI 107122B
Authority
FI
Finland
Prior art keywords
solution
process according
immunoglobulin
viruses
solid phase
Prior art date
Application number
FI923425A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI923425A0 (fi
FI923425A (fi
Inventor
Werner Gehringer
Patrick Selosse
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6437560&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI107122(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of FI923425A0 publication Critical patent/FI923425A0/fi
Publication of FI923425A publication Critical patent/FI923425A/fi
Application granted granted Critical
Publication of FI107122B publication Critical patent/FI107122B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI923425A 1991-08-02 1992-07-29 Menetelmä virusten suhteen inaktivoitujen immunoglobuliiniliuosten valmistamiseksi FI107122B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4125625A DE4125625C2 (de) 1991-08-02 1991-08-02 Verfahren zur Herstellung von virusinaktivierten Immunglobulinlösungen
DE4125625 1991-08-02

Publications (3)

Publication Number Publication Date
FI923425A0 FI923425A0 (fi) 1992-07-29
FI923425A FI923425A (fi) 1993-02-03
FI107122B true FI107122B (fi) 2001-06-15

Family

ID=6437560

Family Applications (1)

Application Number Title Priority Date Filing Date
FI923425A FI107122B (fi) 1991-08-02 1992-07-29 Menetelmä virusten suhteen inaktivoitujen immunoglobuliiniliuosten valmistamiseksi

Country Status (14)

Country Link
US (1) US5648472A (fr)
EP (1) EP0525502B2 (fr)
JP (1) JP2969310B2 (fr)
KR (1) KR100188448B1 (fr)
AT (1) ATE143812T1 (fr)
CZ (1) CZ291813B6 (fr)
DE (2) DE4125625C2 (fr)
DK (1) DK0525502T4 (fr)
ES (1) ES2092604T5 (fr)
FI (1) FI107122B (fr)
IL (1) IL102525A (fr)
SK (1) SK280680B6 (fr)
YU (1) YU48242B (fr)
ZA (1) ZA925764B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4424935C1 (de) * 1994-07-14 1996-03-21 Immuno Ag Humanes virussicheres monomeres Immunglobulin A und Verfahren zu seiner Herstellung
US6136865A (en) * 1995-05-20 2000-10-24 Octapharma Ag Method for reduction of the infectiousness of potentially infectious material
AT403477B (de) * 1996-04-30 1998-02-25 Immuno Ag Biologisches material frei von viralen und molekularen pathogenen und verfahren zur herstellung
IL121900A (en) * 1997-10-07 2001-12-23 Omrix Biopharmaceuticals Ltd A method for the purification of immunoglobulins
ATE224203T1 (de) † 1997-10-23 2002-10-15 Mitsubishi Pharma Corp Bei raumtemperatur lagerfähiges immunoglobolin- präparat für intravenöse injektion
DE10016877A1 (de) * 2000-04-05 2001-10-18 Scintec Diagnostics Gmbh Zug (Glyko-)Proteine mit hoher Immunreaktivität sowie ein Verfahren zu ihrer Herstellung
IL136552A (en) 2000-06-05 2005-05-17 Omrix Biopharmaceuticals Ltd Method for the inactivation of viruses by a solvent - detergent combination and by nanofiltration
US6893639B2 (en) * 2001-10-19 2005-05-17 Hemacare Corporation Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates
WO2003070285A1 (fr) 2002-02-19 2003-08-28 Resolution Chemicals Limited Sterilisation par solvant de composes pharmaceutiques
CN1867582B (zh) * 2003-08-12 2010-06-16 奥克塔法马股份有限公司 制备α-1-抗胰蛋白酶溶液的方法
US6881573B2 (en) * 2003-09-12 2005-04-19 Allan L. Louderback Augmented solvent/detergent method for inactivating enveloped and non-enveloped viruses
US20060234907A1 (en) * 2004-02-13 2006-10-19 Werner Gehringer Albumin solution and process for the production thereof
US7553938B2 (en) 2004-02-27 2009-06-30 Octapharma Ag Method of providing a purified, virus safe antibody preparation
FR2944281B1 (fr) * 2009-04-08 2011-07-29 Fabre Pierre Dermo Cosmetique Derives soufres de resorcinol, leur preparation et leurs utilisations cosmetiques
US11564392B2 (en) * 2017-09-18 2023-01-31 Bayer Healthcare Llc Methods of inactivation of viruses using n-methlyglucamide and its derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57140724A (en) * 1981-02-25 1982-08-31 Green Cross Corp:The Heat-treatment of aqueous solution containing cold insoluble globulin
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
US4481189A (en) * 1982-04-14 1984-11-06 New York Blood Center Inc. Process for preparing sterilized plasma and plasma derivatives
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4789545A (en) * 1986-03-31 1988-12-06 New York Blood Center, Inc. Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof
US4909940A (en) * 1987-12-30 1990-03-20 New York Blood Center, Inc. Extraction of process chemicals from labile biological mixtures with organic alcohols or with halogenated hydrocarbons
US5094960A (en) * 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography

Also Published As

Publication number Publication date
FI923425A0 (fi) 1992-07-29
DK0525502T3 (da) 1997-03-17
DE4125625C2 (de) 1999-12-02
EP0525502B2 (fr) 2005-08-10
IL102525A (en) 2005-05-17
ES2092604T5 (es) 2006-03-01
YU74092A (sh) 1995-10-24
DK0525502T4 (da) 2005-09-19
DE59207324D1 (de) 1996-11-14
ES2092604T3 (es) 1996-12-01
EP0525502A1 (fr) 1993-02-03
JP2969310B2 (ja) 1999-11-02
SK280680B6 (sk) 2000-06-12
ZA925764B (en) 1993-04-28
JPH05202100A (ja) 1993-08-10
KR930004329A (ko) 1993-03-22
EP0525502B1 (fr) 1996-10-09
KR100188448B1 (ko) 1999-06-01
DE4125625A1 (de) 1993-02-04
SK236992A3 (en) 1995-01-05
YU48242B (sh) 1997-08-22
FI923425A (fi) 1993-02-03
CZ236992A3 (en) 1993-02-17
ATE143812T1 (de) 1996-10-15
CZ291813B6 (cs) 2003-06-18
US5648472A (en) 1997-07-15
IL102525A0 (en) 1993-01-14

Similar Documents

Publication Publication Date Title
FI107122B (fi) Menetelmä virusten suhteen inaktivoitujen immunoglobuliiniliuosten valmistamiseksi
KR101206788B1 (ko) 정제된, 바이러스 안전한 항체 제제를 제공하는 방법
US10414816B2 (en) Method for purifying immunoglobulin
US10287315B2 (en) Method for purifying immunoglobulin
IE46304B1 (en) Process of preparing a serum protein composition for intravenous application
CN107849086B (zh) 用于制备源自血浆的乙型肝炎免疫球蛋白的方法
US10358462B2 (en) Method for the preparation of immunoglobulins
AU2016231646B2 (en) Method for the preparation of immunoglobulins
CA2943328C (fr) Methode de preparation d'immunoglobulines
NZ724670A (en) Method for the preparation of immunoglobulins
TW201811815A (zh) 製備免疫球蛋白溶液的方法及其用途